Ispire Technology Inc. (NASDAQ:ISPR) will host its earnings conference call at 8:00 am Eastern Time on Tuesday, Nov. 12, 2024, to discuss the company’s financial results for its fiscal first quarter ended Sept. 30, 2024.
According to Michael Wang, the company’s co-CEO, 2024 was "a foundational year for Ispire." The company reported record revenue and substantial margin expansion while “strategically positioning us for faster growth in our global nicotine business and intentionally focusing our cannabis vaping hardware on high-quality multi-state operator (MSO) customers,” Wang continued.
Revenue increased 31.4% year-over-year to $151.9 million as compared to $115.6 million in the 2023 fiscal year.
During an interview on Benzinga’s Cannabis Insider podcast earlier this year Wang said that “vaping will become the number one way for using cannabis within the next 2 or 3 years.”
Ispire's shares traded 5.56% lower at $6.12 per share at the time of writing on Thursday.
Read Also: Cannabis Vape Tech Producer Ispire Enters South African Market Via Exclusive Deal With Dank Pack
Vertically-integrated California cannabis company Gold Flora Corporation (Cboe Canada: GRAM) (OTCQB:GRAM) will report financial results on Thursday, Nov. 14 for the third quarter ended Sept. 30, 2024. The company will host a conference call to discuss the results at 6:00 pm Eastern Time, on the same day.
The second quarter earnings report made public in August revealed $31.64 million in revenue for the period, reflecting a slight decrease of 2% from the previous quarter. Gross profit dropped significantly by 28%, totaling $7.25 million in the second quarter, resulting in a gross margin of 23%.
In October, Gold Flora’s common shares were approved to quote on the OTC Market’s Group Inc.’s OTCQB Venture Market in the U.S. under the ticker symbol “GRAM."
Vext Science, Inc. (CSE:VEXT) (OTCQX:VEXTF) a U.S.-based cannabis operator with vertical operations in Arizona and Ohio plans to release its financial results before the market opens on Nov. 21 for the third quarter ending Sept. 30, 2024, The earnings conference call and webcast will take place on the same day at 08:00 am Eastern Time.
Pablo Zuanic, senior analyst at Zuanic & Associates initiated coverage of Vext Science with an Overweight rating earlier this year, highlighting the company's significant growth potential.
As highlighted by Benzinga’s Nicolás Jose Rodriguez, Zuanic calculated that Vext has the most EBITDA torque among the twelve public multi-state operators (MSOs) in Ohio, projecting Vext's EBITDA could grow six-fold by calendar 2026, taking calendar 2023 as the base year. Recreational marijuana sales launched across Ohio on Tuesday, Aug. 6.
Read Next:
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。